16 August 2018
Visiongain’s new report Global Ophthalmic Devices Market 2017-2027: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others indicates that the global ophthalmic devices market will see $24.19bn in spending in 2021.
The global ophthalmic devices market is expected to grow at a CAGR of 5.7% in the first half of the forecast period. The market is expected to grow at a CAGR of 6.4% from 2017-2027. The market is estimated at $18.33bn in 2016 and $24.19bn in 2021. In 2016, the surgical devices submarket held the largest market share at 45.9%, followed by the vision care submarket at 41.7%.
The lead analyst of the report said: “ The main drivers of growth in this market will be an ageing global population, higher incidence of diabetes resulting in related ocular problems, rapid growth in the emerging economies and innovative technologies. Current limitations of pharmaceutical treatments, as well of ophthalmic diagnostics and monitoring and surgical devices will continue to drive innovation. Patient compliance and cost effectiveness will be the key factors to be considered in developing new devices”
The 190-page report contains 67 tables and 58 figures that add visual analysis in order to explain the developing trends within the Global Ophthalmic Devices Market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the global ophthalmic devices market and its leading submarkets: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others.
The 190-page report offers market forecasts for the US, Germany, France, The UK, Italy, Spain, Japan, China, Brazil, Russia, India, South Korea and Rest of the World
Moreover, our work discusses the leading companies in the ophthalmic devices market. Our study also discusses Porter’s Five Forces analysis that influence the global ophthalmic devices market
The report Global Ophthalmic Devices Market 2017-2027: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others report will be of value to anyone who wants to better understand the ophthalmic devices market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the ophthalmic devices market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The colon targeting drug delivery market has been used various polymers including biodegradable polymers, guar gum, pectin, chondroitin sulfate, dextran, chitosan, cyclodextrin, inulin, amylose, locust bean gum, and others
23 September 2019
Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine.
20 September 2019
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
10 September 2019
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.